monoclonal antibody
FDA Approves Enflonsia, Second RSV Antibody for Infants
The FDA has approved the second monoclonal antibody for the prevention of RSV in neonates and infants, ...
JUNE 10, 2025
FDA Approves Veopoz for CHAPLE Disease
The FDA approved Veopoz as the first treatment for CD55-deficient protein-losing enteropathy, also known as CHAPLE ...
AUGUST 21, 2023
FDA Limits Use of Monoclonal Antibodies to Treat COVID-19
The FDA revised the EUAs for two monoclonal antibody cocktails for COVID-19, essentially saying the should not be ...
JANUARY 25, 2022
Regen-COV Reduces Viral Load in Patients Hospitalized with COVID-19
The monoclonal antibody cocktail may be as useful in the hospital as it is in the outpatient setting.
OCTOBER 5, 2021
JAK Inhibitors, IL-6 Blockers for COVID-19: Where Do They Fit?
Another JAK inhibitor appears effective in reducing death and respiratory failure in patients hospitalized with ...
JULY 7, 2021
FDA Authorizes Lower Dose of Regen-Cov mAb Cocktail
The FDA updated the emergency use authorization (EUA) for Regeneron’s Regen-Cov, lowering the dose to 1,200 ...
JUNE 4, 2021
Challenges to Uptake of Monoclonal Antibody Therapies for COVID-19: Lessons Learned
Issues identified in the introduction and uptake of monoclonal antibody therapies for COVID-19 offer key insights ...
APRIL 21, 2021
FDA Approves Takhzyro for Rare Hereditary Angioedema
Takhzyro is the first monoclonal antibody approved in the United States to prevent attacks of hereditary angioedema ...
AUGUST 27, 2018
Aimovig Gets FDA Nod for Migraine Prevention
Aimovig is the first FDA-approved treatment to block the calcitonin gene–related peptide receptor, which ...
MAY 18, 2018
Dose Rounding Monoclonals Yields Windfall
Rounding down doses for injectable monoclonal antibodies within 10% to achieve more efficient use of vial sizes ...
FEBRUARY 7, 2017
FDA Approves Taltz To Treat Psoriasis
Psoriasis affects about 7.5 million Americans, 20% of whom have moderate to severe plaque psoriasis.
MARCH 23, 2016
